NCT05757726View on ClinicalTrials.gov

Early Feasibility of the Velocity™ Percutaneous PAVF System

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 14, 2023

Primary Completion Date

November 15, 2023

Study Completion Date

October 8, 2024

Conditions
Arteriovenous Fistula
Interventions
DEVICE

Velocity pAVF system

A second generation percutaneous AVF device that creates an AVF between the proximal radial artery and cubital perforating vein.

Trial Locations (1)

Unknown

Sanatorio Italiano, Asunción

Sponsors

Lead Sponsor

Venova Medical
All Listed Sponsors
lead

Venova Medical

INDUSTRY

NCT05757726 - Early Feasibility of the Velocity™ Percutaneous PAVF System | Biotech Hunter | Biotech Hunter